This sheet is about exposure to labetalol in pregnancy and while breastfeeding
Suggested first line antihypertensive drugs that are safe in breastfeeding mothers include labetalol, nifedipine, and enalapril Refer women with persistent hypertension or proteinuria six weeks after
Labetolol, a beta blocker often used for high blood pressure during pregnancy, is safer to continue postpartum for a breastfeeding mother than atenolol
Be sure to talk to your
There is limited information about the use of antihypertensive drugs in the postnatal period, particularly in women who choose to breastfeed, and some antihypertensive drugs are
Objective: To determine whether oral labetalol is associated with a shorter time to blood pressure control compared to oral extended release nifedipine for management of persistent postpartum hypertension
acutely with labetalol orally or intravenously, intravenous hydralazine or nifedipine orally (Table 1)
Labetalol, hydralazine, and nifedipine are all effective for acute management, although nifedipine may work the fastest
Contextual Question
i
33 Prior studies have addressed differences in time to blood pressure control with the use of IV hydralazine compared to IV labetalol and Beta-blockers work by slowing the heart rate and opening up blood vessels to improve blood flow
Maximum dose: Some patients may require 1200 to 2400 mg orally per day For labetalol hydrochloride
• Use medicines that are taken once daily when possible
The lacosamide level in milk on day 5 postpartum (exact time unspecified) was 0
She began breastfeeding on day 3 postpartum and had a seizure on day 7 postpartum
2 per 100,000 deliveries and The most common side effects that can occur with labetalol include: dizziness
Find out how labetalol treats high blood pressure (hypertension) including high blood pressure in pregnancy and angina, and how to take it
Labetalol is often chosen as treatment of acute hypertension by anesthesia providers peri-operatively as it produces a dose-related decrease in blood pressure without reflex tachycardia without significant reduction in heart rate